Growth Metrics

Legend Biotech (LEGN) Interest & Investment Income (2020 - 2025)

Legend Biotech filings provide 6 years of Interest & Investment Income readings, the most recent being $7.9 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 42.34% to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $40.0 million, a 34.61% decrease, with the full-year FY2025 number at $40.1 million, down 34.48% from a year prior.
  • Interest & Investment Income hit $7.9 million in Q4 2025 for Legend Biotech, down from $9.7 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $17.0 million in Q2 2024 to a low of -$18.4 million in Q3 2023.
  • Median Interest & Investment Income over the past 5 years was -$127000.0 (2021), compared with a mean of $2.7 million.
  • Biggest five-year swings in Interest & Investment Income: crashed 1374.89% in 2023 and later surged 305.33% in 2024.
  • Legend Biotech's Interest & Investment Income stood at -$971000.0 in 2021, then crashed by 742.64% to -$8.2 million in 2022, then tumbled by 125.13% to -$18.4 million in 2023, then surged by 174.38% to $13.7 million in 2024, then crashed by 42.34% to $7.9 million in 2025.
  • The last three reported values for Interest & Investment Income were $7.9 million (Q4 2025), $9.7 million (Q3 2025), and $10.4 million (Q2 2025) per Business Quant data.